Your browser doesn't support javascript.
loading
Conditions of validation and use of the screening method for vaccine efficacy evaluation.
Mary-Krause, M; Mary, J Y; Valleron, A J.
Afiliação
  • Mary-Krause M; B3E-INSERM U.263 Faculté de médecine Saint-Antoine, Paris, France.
Rev Epidemiol Sante Publique ; 41(2): 155-60, 1993.
Article em En | MEDLINE | ID: mdl-8493394
ABSTRACT
If PV is the proportion of the target population vaccinated and PCV the proportion of cases in the same population who have been previously vaccinated, vaccine efficacy can be computed as (PV-PCV)/[PV(1-PCV)]. In the screening method, this formula is currently applied to sample values. The objective of this paper is to provide the corresponding statistical tools. Taylor series expansion has been used to derive the bias, variance and confidence interval of the estimate. The bias may be very high when vaccine efficacies are low. It is below 1% for vaccine efficacies higher than 80%. Monte Carlo simulations were used to assess the departure from normality of the estimate. The number of subjects required by the method for given precisions are presented.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Interpretação Estatística de Dados Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Rev Epidemiol Sante Publique Ano de publicação: 1993 Tipo de documento: Article País de afiliação: França
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Interpretação Estatística de Dados Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Rev Epidemiol Sante Publique Ano de publicação: 1993 Tipo de documento: Article País de afiliação: França